Related references
Note: Only part of the references are listed.Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
Jonathon M. Tinsley et al.
PLOS ONE (2011)
Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice
Alison R. Amenta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Survival of Myoblasts After Intramuscular Transplantation Is Improved When Fewer Cells Are Injected
Kathryn L. Pellegrini et al.
TRANSPLANTATION (2011)
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
Aurelie Goyenvalle et al.
SKELETAL MUSCLE (2011)
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers
Natee Jearawiriyapaisarn et al.
CARDIOVASCULAR RESEARCH (2010)
Mesenchymal stem cells as anti-inflammatories: Implications for treatment of Duchenne muscular dystrophy
Thomas E. Ichim et al.
CELLULAR IMMUNOLOGY (2010)
Molecular treatments in Duchenne muscular dystrophy
Michela Guglieri et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
B. Wu et al.
GENE THERAPY (2010)
The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice
Maria Grazia Di Certo et al.
HUMAN MOLECULAR GENETICS (2010)
Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin
Dejia Li et al.
JOURNAL OF CELL SCIENCE (2010)
Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
Richard S. Finkel
JOURNAL OF CHILD NEUROLOGY (2010)
CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres
Margaret Durko et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2010)
Targeting Fibrosis in Duchenne Muscular Dystrophy
Lan Zhou et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Expression of Dog Microdystrophin in Mouse and Dog Muscles by Gene Therapy
Christophe Pichavant et al.
MOLECULAR THERAPY (2010)
Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping
Aurelie Goyenvalle et al.
MOLECULAR THERAPY (2010)
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
Yasuhiro Kazuki et al.
MOLECULAR THERAPY (2010)
24 week follow-up data from a phase I/IIa extension study of PRO051/GSK2402968 in subjects with Duchenne muscular dystrophy
N. Goemans et al.
NEUROMUSCULAR DISORDERS (2010)
Current progress and preliminary results with the systemic administration trial of AVI-4658, a novel phosphorodiamidate morpholino oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD)
S. B. Shrewsbury et al.
NEUROMUSCULAR DISORDERS (2010)
Brief Report: Dystrophin Immunity in Duchenne's Muscular Dystrophy.
Jerry R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
RhoA leads to up-regulation and relocalization of utrophin in muscle fibers
Cecile Gauthier-Rouviere et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Pharmacological activation of PPARβ/δ stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice
Pedro Miura et al.
HUMAN MOLECULAR GENETICS (2009)
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
Yi Lai et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Interventions for muscular dystrophy: molecular medicines entering the clinic
Kate Bushby et al.
LANCET (2009)
Mammalian animal models for Duchenne muscular dystrophy
Raffaella Willmann et al.
NEUROMUSCULAR DISORDERS (2009)
Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice
Kevin J. Sonnemann et al.
PLOS MEDICINE (2009)
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2008)
Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice
Haifang Yin et al.
MOLECULAR THERAPY (2008)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength
C. E. Ambrosio et al.
NEUROMUSCULAR DISORDERS (2008)
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
Bo Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice
Rachid Benchaouir et al.
CELL STEM CELL (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Autologous transplantation of muscle-derived CD133(+) stem cells in Duchenne muscle patients
Y. Torrente et al.
CELL TRANSPLANTATION (2007)
Overactivity of exercise-sensitive cation channels and their impaired modulation by IGF-1 in mdx native muscle fibers: Beneficial effect of pentoxifylline
Jean-Francois Rolland et al.
NEUROBIOLOGY OF DISEASE (2006)
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
Maurilio Sampaolesi et al.
NATURE (2006)
Molecular mechanisms of muscular dystrophies: old and new players
Kay E. Davies et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy
KA Kleopa et al.
HUMAN MOLECULAR GENETICS (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia
S Acharyya et al.
CANCER CELL (2005)
Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction
LM Angus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin
S Li et al.
GENE THERAPY (2005)
Identification of spectrin-like repeats required for high affinity utrophin-actin interaction
IN Rybakova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury
MJ Liu et al.
MOLECULAR THERAPY (2005)
ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to β-dystroglycan
M Ishikawa-Sakurai et al.
HUMAN MOLECULAR GENETICS (2004)
Therapeutics for Duchenne muscular dystrophy: current approaches and future directions
S Bogdanovich et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Heregulin ameliorates the dystrophic phenotype in mdx mice
TOB Krag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Isolation and enrichment of skeletal muscle progenitor cells from mouse bone marrow
S Bhagavati et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Pharmacological strategies for muscular dystrophy
TS Khurana et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer
M Cerletti et al.
GENE THERAPY (2003)
Prevention of pathology in mdx mice by expression of utrophin:: analysis using an inducible transgenic expression system
S Squire et al.
HUMAN MOLECULAR GENETICS (2002)
High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy
AM Connolly et al.
NEUROMUSCULAR DISORDERS (2002)
A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle
AP Weir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The urokinase plasminogen activator: An interesting way to improve myoblast migration following their transplantation
E El Fahime et al.
EXPERIMENTAL CELL RESEARCH (2002)
Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: Toward defining strategies applicable to humans
D Skuk et al.
EXPERIMENTAL NEUROLOGY (2002)
The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy
KJ Perkins et al.
NUCLEIC ACIDS RESEARCH (2001)
Non-toxic ubiquitous over-expression of utrophin in the mdx mouse
R Fisher et al.
NEUROMUSCULAR DISORDERS (2001)
Three mouse models of muscular dystrophy:: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice
AM Connolly et al.
NEUROMUSCULAR DISORDERS (2001)
Absence of MyoD increases donor myoblast migration into host muscle
GM Smythe et al.
EXPERIMENTAL CELL RESEARCH (2001)
Absence of desmin slightly prolongs myoblast proliferation and delays fusion in vivo in regenerating grafts of skeletal muscle
GM Smythe et al.
CELL AND TISSUE RESEARCH (2001)
Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology
YW Chen et al.
JOURNAL OF CELL BIOLOGY (2000)
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy
M Sander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin
ME Adams et al.
JOURNAL OF CELL BIOLOGY (2000)
The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin
IN Rybakova et al.
JOURNAL OF CELL BIOLOGY (2000)
In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity
E El Fahime et al.
EXPERIMENTAL CELL RESEARCH (2000)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
T-cell-dependent fibrosis in the mdx dystrophic mouse
J Morrison et al.
LABORATORY INVESTIGATION (2000)
The artificial zinc finger coding gene 'Jazz' binds the utrophin promoter and activates transcription
N Corbi et al.
GENE THERAPY (2000)
Share Paper
